window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 17, 2026

  • News
  • About Us
Contact Us

Uncategorised

  • Uncategorised

    Prosper AI raises $5M to expand AI-driven healthcare voice platform

    Artificial intelligence is reshaping the pharmaceutical and healthcare industries, accelerating [...]

    October 3, 2025
  • CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Supply Chain & Logistics,Technology and platforms,Uncategorised

    CPHI Frankfurt 2025 set to welcome more than 60,000 global pharma professionals

    CPHI Frankfurt 2025 will bring the world’s pharmaceutical community back [...]

    September 11, 2025
  • Uncategorised

    Camena Bioscience and Constructive Bio team up in £9.1m project to build synthetic plant genomes

    Two UK-based innovators, Camena Bioscience and Constructive Bio, have joined [...]

    August 15, 2025
  • Uncategorised

    FDA clears Daxor’s next-generation blood volume analyzer for precise fluid management

    Daxor Corporation, a global leader in blood volume measurement technology, [...]

    August 8, 2025
  • CDMOs & Manufacturing,Regulatory Affairs,Supply Chain & Logistics,Uncategorised

    Cherwell to become AnalytiChem UK from September 2025

    Cleanroom microbiology solutions specialist Cherwell is set to be renamed [...]

    August 7, 2025
  • Uncategorised

    Pharvaris eyes 2026 filing as Phase 3 HAE trial timeline shifts

    Pharvaris has adjusted its guidance for topline results from its [...]

    July 10, 2025
  • Uncategorised

    Actithera raises $75.5M to advance precision radioligand therapies targeting difficult-to-drug tumors

    Oversubscribed Series A financing led by M Ventures, Hadean, Sofinnova [...]

    July 9, 2025
  • Uncategorised

    ten23 health joins Alliance for RTU to advance sterile manufacturing standards

    ten23 health has joined the Alliance for RTU, a technical [...]

    June 30, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Precision medicine,Technology and platforms,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    June 5, 2025
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top